GVS Group, which makes biohazard masks and medical filters, boosted production of its filters for pulmonary ventilators and masks, some of which it tests with a live virus. The company went public on the Milan stock exchange on Friday, closing with a market capitalization of $1.9 billion. GVS had been mulling an IPO since September 2019, but those plans were set back by the Covid-19 outbreak. Revenues grew 9% in 2019 to $259 million (230.6 million euros) and net profits rose 43% to $37 million (33.1 million euros). Even after the Covid-19 pandemic is long gone, Scagliarini is confident that there will be greater need for the company’s products.

Source: Forbes June 19, 2020 17:03 UTC